VitaDX
PrivateLast Round
VC Round
Jun 20, 2025
Total Funding Raised
$3.12M
Company Overview
VitaDX operates in Healthcare & Life Sciences and is based in Rennes. Its latest recorded funding round was a VC Round in June 2025.
VitaDX is a med-tech company that develops and commercializes cancer diagnostic solutions combining image analysis and artificial intelligence with its patented VisioCyt® technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VitaDX Comparables
Compare VitaDX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIxMed, Inc. | 86% | |
| OncoDiag | 79% | |
| Cellens Inc. | 78% |
For institutional investors. Book with your work email.
VitaDX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 20, 2025 | ||||
| VC Round | Sep 4, 2020 | ||||
| VC Round | Jun 24, 2019 | ||||
| Seed | Jun 7, 2017 | ||||
| Angel | Jul 1, 2015 | ||||
Grant | Apr 28, 2015 |
For institutional investors. Book with your work email.
VitaDX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Odyssée Venture | VC Round |
| Office National d'Études et de Recherches Aérospatiales | Grant |
| GO Capital | VC Round, Seed |
| Auriga Partners | Seed, VC Round |
| SATT Paris-Saclay | Grant |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Grew 24% QoQ from 21 to 26 employees.
- Jan 25, 2026
Monthly visitors grew 464% MoM, reaching 1K.
For institutional investors. Book with your work email.
VitaDX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VitaDX's valuation, stock price, and market status.
Is VitaDX a public or private company?
VitaDX is a private company.
What is the current stock price of VitaDX?
VitaDX is a private company, so its shares have no public market price. Caplight tracks VitaDX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VitaDX worth (valuation)?
Valuation information for VitaDX is not publicly available.
Can I buy VitaDX stock?
VitaDX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VitaDX's last funding round?
VitaDX's most recent funding round was VC Round on June 20, 2025.
Who are the main investors in VitaDX?
Key investors in VitaDX include Odyssée Venture, GO Capital.
Will VitaDX IPO soon?
No public IPO plans have been announced for VitaDX.
How can I track VitaDX secondary market activity?
Caplight tracks bids, offers, and trades in VitaDX's shares on secondary markets.